Delivery Order SPE2DX22D0010-SPE2D824FJW33
Award Date
2/21/24
Potential Completion Date
2/22/24
Potential Value
$18K
Federal Agency
Medical Supply Chain
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,724.50 firm-fixed-price delivery order is for the supply of Focalin XR Capsules, 20mg, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of November 21, 2024. Amerisourcebergen holds a significant $999,999,999...
This federal contract award, valued at $13,324.07, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,946 units of Focalin XR 10 mg capsules, a pharmaceutical product used to treat Attention Deficit Hyperactivity Disorder (ADHD). The contract is a Firm Fixed Price Delivery Order with a period of performance through November 30, 2023. This award is not associated with any set-aside...
This federal contract award, valued at $4,186.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Focalin XR 5 mg capsules, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). The contract is a Firm Fixed Price Delivery Order, with a period of performance running through February 14, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,260.07, is for the supply of FOCALIN XR CAPS 20MG, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of January 8, 2025 and is a firm fixed-price delivery order. There is no set-aside designation for this award. Amerisourcebergen holds a...
This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 100 units of Focalin XR 15 mg capsules, a pharmaceutical product used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a ceiling value of $4,463.16 and an ultimate completion date of November 17, 2023. This contract is a delivery order under a larger Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,345.47, is for the supply of Focalin XR Capsules 10mg, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of November 21, 2023. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award, valued at $7,357.24, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, covers the supply of FOCALIN XR CAPS 15MG, a medication used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). The contract has an ultimate...
This federal contract award, valued at $2,127.60, was issued by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA) Troop Support. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Focalin XR capsules, a medication used to treat attention deficit hyperactivity disorder (ADHD). The contract has a completion date of September 24, 2024 and is structured as a firm-fixed price delivery order. This award is not...
This federal contract award, valued at $1,678.84, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
This federal contract award, valued at $6,861.52, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Focalin XR capsules, a brand-name medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). This award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through...